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Abstract:
Although  over  80  cytochrome  P450  (CYP)  encoding  genes  have  been  identified  in  the 
genome of the nematode Caenorhabditis elegans very little is known about their involvement 
in biotransformation. This paper demonstrates a concentration dependent relationship of  C. 
elegans CYP35A1, A2, A5, and C1 gene expression in response to four organic xenobiotics, 
namely atrazine,  PCB52, fluoranthene,  and lansoprazole. The toxicity of these xenobiotics 
was determined using a reproduction assay. CYP-specific messenger RNA expression was an-
alyzed by semi-quantitative RT-PCR resulting in a strongly increasing, concentration-depen-
dent induction well below the EC50 for reproduction. For PCB52, approximately 0.5 % of the 
EC50 induces a two-fold increase of CYP35 gene expression. Using a double mutant and mul-
tiple  RNAi of CYP35A/C it  was possible  to diminish the reproduction decline caused by 
PCB52 and fluoranthene.
Key words: Caenorhabditis  elegans,  Cytochrome P450,  CYP35,  Organic  xenobi-
otics, Gene expression, Reproduction assay, RNAi
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Introduction
The nematode Caenorhabditis elegans is perhaps the only multi-cellular animal hav-
ing the experimental convenience of a single-celled organism [1]. The worm’s short life cy-
cle, developmental invariance, and the completion of its genome sequence are greatly advan-
tageous. During the last decades, its culture conditions, anatomy, genetic properties, and de-
velopmental  staging have been better  defined than for any other animal.  Nevertheless, the 
knowledge  about  one  of  the  most  numerous  and  diverse  enzyme  superfamilies,  the  cy-
tochromes P450, and their functional importance in the nematode, is rather limited. In excess 
of 80 cytochrome P450 genes (CYP) have been identified to be present in the genome of C. 
elegans (http://drnelson.utmem.edu/CytochromeP450.html), and with the exception of CYP22 
[2,3] almost nothing is known about them.
CYP genes are found in all eukaryotes and most bacteria and Archaea. They code for 
NADPH dependent monooxygenases involved in the metabolism of various endogenous and 
exogenous compounds. The cytochrome P450 enzymes have, in particular, been implicated in 
the bioactivation  or detoxification of many hydrophobic  drugs and xenobiotics.  The CYP 
gene expression can be modulated by these substances [4–8], and the potential of xenobioti-
cally induced gene expression has been established both in toxicological and ecotoxicological 
studies [9,10].
A previous study [11] investigated the potential of 18 different xenobiotics to induce 
C. elegans CYPs. It could be shown that in particular CYP35s are strongly inducible by poly-
cyclic aromatic hydrocarbons (PAH), polychlorinated biphenyls (PCB) and certain drugs. Our 
ongoing interest is to further characterize the CYP specific genetic response and thereby not 
only provide new insights regarding the nematode’s reaction to man-made chemical stress, 
but also exploit  CYP as a biomarker for common environmental  stressors.  C. elegans has 
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proven useful in classical in vivo toxicity testing (lethality, reproduction, growth or develop-
mental  toxicity)  [12–14]  as  well  as  in  more  recently  developed  molecular  biological  ap-
proaches like differential display [15,16], and DNA microarray analyses [17,18]; or systems 
with transgenic animals [19–22]. This latter system is based on heat shock promoter elements 
inducible by various kinds of natural and man-made stress. A CYP promoter driven reporter 
construct, in contrast, should have an increased substance class specific response potential.
This paper reports concentration dependent relationships of CYP35A1, A2, A5, and 
C1 gene expression in response to four different xenobiotics. The selected compounds com-
prise representative substances of ecotoxicological relevant groups: a PAH (fluoranthene), a 
polychlorinated biphenyl (PCB52), an herbicide (atrazine), and the ulcer preventive pharma-
ceutical lansoprazole.
In parallel to the effect monitoring on the molecular level, the toxicity of the four sub-
stances was analyzed using a reproduction assay in liquid medium. In addition, the conse-
quences of CYP35A/C1 gene knockdown were determined by gene disruption and RNA in-
terference (RNAi) in the presence and absence of xenobiotics. The authors postulate that the 
specific knockdown of all CYP35A forms and C1 results in a significant change in sensitivity 




Throughout this study either C. elegans wild type strain Bristol N2 was used or a ho-
mozygous double mutant XA6700, which was generated by crossing cyp-35A2 (gk317) and 
cyp-35A4 (ok1393). Synchronous worms were generated by rinsing worms from NGM plates 
4
and subsequently filtered through a 10 µm membrane filter (SM 16510/11, Sartorius, Ger-
many) which retains all but first-stage juveniles. With the exception of the RNAi experiments, 
worms were cultivated in S basal liquid medium [23] at 25°C with Escherichia coli OP50 as a 
food source. The following exposure protocol was used per replicate for all experiments: 10 
L1 larvae, 250 µg (fresh weight) E. coli OP50 and the xenobiotic, dissolved in 0.3 µl DMSO 
were added to 100 µl S basal liquid medium in a small glass vessel,
Xenobiotics
The effects  of the following xenobiotics  were analyzed:  Atrazine [2-chloro-4-ethy-
lamino-6-isopropylamino-1,3,5-triazin]  (Riedel  de  Haën,  Germany);  fluoranthene 
[Benzo[j,k]fluorine]; lansoprazole [C16H14F3N3O2S] and PCB52 [2,2',5,5'-tetrachlorbiphenyl]. 
If not stated otherwise the chemicals were obtained from Sigma-Aldrich, Germany. Due to 
their hydrophobic nature, the selected compounds had to be dissolved in an organic solvent. 
After a detailed selection procedure including different concentrations of ethanol, methanol, 
and DMSO, a final concentration of 0.3 % (v/v) DMSO in the medium was found to have no 
effect on reproduction of the nematodes and CYP35 mRNA expression.
Reproduction test
First-stage juveniles were initially transferred by micropipette to the test glass vessels 
containing 100 µl of liquid medium. The samples were placed in an incubator at 25°C for 4 
days (96 ± 2 h). For each xenobiotic two controls, with or without 0.3 % DMSO, respectively 
and a dilution series of five to six concentrations was used. Twelve replicates were used for 
each test concentration. At the end of the exposure period the number of living adult individu-
als was noted and the offspring, regardless of the developmental stage, was determined. Final-
ly offspring per worm was calculated from the number of second-generation juveniles per test 
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vessel. After the 96-h exposure period, the number of offspring was calculated from the num-
ber of second-generation juveniles at all stages. The reproduction rate in the control without 
solvent was 152.95 ± 15.69 (SD) and 142.05 ± 14.61 (SD) in the control with 0.3 % DMSO 
(in both cases n=60). The effect concentrations (EC50) were calculated by probit analysis.
RNA Preparation and semi-quantitative RT-PCR
Nematodes were harvested as young adults (after 48 h) for the preparation of RNA . 
The RNA isolation followed standard procedures using Trizol reagent (Invitrogen), however 
modified to include a homogenization step with 0.5 mm glass beads to maximize cell break-
age. Subsequently, RNA was purified using an RNeasy kit followed by a DNase digestion kit 
(QIAGEN).  The  reverse  transcription  was  performed  using  M-MLV reverse  transcriptase 
(PROMEGA) at 42°C for 90 min. Thereafter a PCR amplification of the act-1 cDNA was per-
formed  using the HotStar  Taq DNA polymerase  system from QIAGEN with the primers 
act1-1 (5’ GAGGCCCAATCCAAGAGA 3’) and act1-2 (5’ TGTTGGAAGGTGGAGAGG 
3’). To quantify amplified DNA, the PCR samples were separated in an agarose gel and im-
aged using an AlphaImager 2200 (Alpha Innotech Corp., USA). The appropriate cDNA dilu-
tions were empirically determined to ensure that the PCR amplification of  act-1 cDNA, as 
well as of each CYP35 cDNA, did not reach saturation. In each case calibration curves were 
constructed with known amounts of a commercial DNA mass standard. In the next step, the 
cDNA amounts  used for the CYP35 PCRs were determined,  calculating  the  act-1 cDNA 
amount as internal standard (for CYP35 gene specific primers see [11]). To minimize poten-
tial  error due to cDNA variability,  the data was presented as a relative ratio between the 




The RNAi feeding assay was performed on NGM agar plates. For each of the five 
CYP35A genes and for CYP35C1 an individual bacterial feeding strain was generated. We 
used the L4440 feeding vector [24] as a basis for cloning of restriction fragments of previous-
ly isolated CYP35A1-5/C1 cDNAs. In reference to the coding sequence the resulting inserts 
correspond with +21 to +899 (35A1), +1 to +748 (35A2), +1 to +1183 (35A3), +1 to +798 
(35A4), +21 to +1100 (35A5), and +514 to +816 (35C1), respectively.  The resulting plas-
mids, and an empty control vector, were transformed separately into the E. coli feeding strain 
HT115(DE3). The cultivation and induction of the bacteria followed in principal the instruc-
tions of Hull and Timmons [25]. Briefly, the plasmid carrying HT115(DE3) strains were cul-
tivated in the presence of 50 µg/ml Ampicilin and 12.5 µg/ml Tetracycline until the freshly 
inoculated culture reached OD600= 0.4–0.6. IPTG was added to a final concentration of 0.4 
mM, and the culture incubated for an additional four hours at 37°C. The cells were harvested 
by centrifugation, if multiple RNAi feeding strains were utilized equal amounts of cell sus-
pension were harvested. The bacteria were resuspended in resh LB medium, spiked with addi-
tional antibiotics (50 µg/ml Ampicilin, 12.5 µg/ml Tetracycline) and IPTG (to a final concen-
tration of 0.8 mM). Finally, the cells were added to NGM agar plates, containing the same 
concentration of antibiotics and IPTG as described below. If a xenobiotic treatment was per-
formed, fluoranthene (0.5 mg/L), PCB52 (10 mg/L), lansoprazole (10 mg/L) or atrazine (50 
mg/L) were added to both the bacterial suspension and to the agar. In each case an individual 
first-stage juvenile of N2 wild type or XA6700 was transferred to each plate. Commencing 
with the egg laying  period,  each  parental  worm was transferred to  new,  freshly prepared 
RNAi feeding plates at regular intervals to facilitate the counting the entire F1 generation. 
Each experiment was performed twelve times.
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To ensure that dsRNA feeding was successful, 10 adult worms from each RNAi condi-
tion were assessed by CYP35A specific RT-PCRs (for details see paragraph before). To ob-
tain an overview regarding potential cross reactivities, these control experiments were per-
formed with 5 mg/L PCB52 induced N2 wild type. To exclude the possibility that traces of 
the original feeding construct were amplified in the RT-PCR different reverse primers (Tab. 
1) were used, binding in each case outside of the derived RNAi construct in the 3’ non coding 
region.
Data analysis
For the reproduction assay (n=12), the relative reproduction [%] was calculated rela-
tive to the control (treated with 0.3 % DMSO). For the RNAi test (n=12), the total amount of 
F1 offspring was determined. All data were analyzed using the SPSS computer software. If 
the data were normally distributed, a one way ANOVA was run to test significant differences 
between treatments followed by the Bonferroni T test to identify treatments that were signifi-
cantly different from the control. If there was a lack of homogeneity of normality, the non-
parametric Kruskal-Wallis one way analysis of variance on ranks was used followed by the 
Dunnett’s test. The effect concentrations were determined using the probit analysis according 
to Finney [26]. For the RT-PCR tests (n=3), the concentration response plots were fitted to the 
respective data using Sigma Plot 2001 (SPSS), for statistical comparison the standard devia-
tion is presented.
Results
Dose dependent induction of CYP gene expression
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In the semi-quantitative RT-PCR assay, all four xenobiotics caused a strong and repro-
ducible induction of CYP35A1, A2, A5, and C1 gene expression. Fig. 1 presents representa-
tive DNA agarose gels showing the relative gene expression of each individual CYP form in 
relation to act-1, an invariant housekeeping gene in response to the respective xenobiotics. It 
is obvious that the increasing concentrations of the chemicals did not affect the actin gene ex-
pression, whereas the expression of all CYP35 genes increased in a concentration dependent 
manner.
The semi-quantitative evaluation of the data is presented in Fig. 2. This figure shows 
the increase of CYP35 specific gene expression (n=3), normalized to the act-1 expression as 
internal control. A two-fold increase in gene expression was defined as the cut-off, highlight-
ed in the graph by dashed lines. The concentration of each xenobiotic substance is shown on a 
molar basis (µmol/L), facilitating the comparison between the RT-PCR results and the toxic 
potency determined by the reproduction assay. PCB52 displayed the most significant CYP35 
induction (Fig. 2B), where (with the exception of CYP35A5) 0.342 µmol/L (0.1 mg/L) result-
ed in excess of a two-fold increase. In the case of the PAH fluoranthene, 1.236 µmol/L (0.25 
mg/L) was found to be sufficient to induce a two-fold increase of CYP35A1 and A5 gene ex-
pression (Fig. 2A). 1.353 µmol/L (0.5 mg/L) of the ulcer preventing drug lansoprazole also 
caused a two-fold increase of CYP35A1 and A2 (Fig. 2C). Atrazine (Fig. 2D) was found to be 
a less potent CYP35A/C inducer than the other chemicals, as the cut-off level for CYP35A1 
and C1 induction was reached at concentrations equal or higher than 23.18 µmol/L (5 mg/L). 
Based on the combined data, but excluding the fluoranthene results, there is evidence that 
CYP35A5 gene induction is the least sensitive and CYP35A2 the most response CYP tested.
Reproduction assay
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Fig. 3A–D visualizes the concentration effect relationship for fluoranthene, PCB52, 
lansoprazole, and atrazine as relative data (% reproduction) in single box plots. The associat-
ed control values were set to 100%. All xenobiotics negatively affect the reproduction in a 
strong concentration dependent manner with increasing concentrations causing decreasing re-
production. Only with lansoprazole, a hormetic effect was observed; low concentrations in-
creased reproduction of C. elegans. While fluoranthene was the most toxic compound used in 
the study, the worms were insensitive to the herbicide atrazine. Based on the EC50, the follow-
ing order of toxicity was observed: Fluoranthene > PCB52 > lansoprazole > atrazine.
Efficacy of CYP35A RNAi
Based on the knowledge that CYP35A forms were found to be strongly inducible by 
PAK and PCB, it  was  considered important to analyze the effect  of their  gene expression 
knockdown during a continued xenobiotic exposure. RNAi refers to the introduction of ho-
mologous double stranded RNA (dsRNA) to specifically target a gene's mRNA, resulting in 
null or hypomorphic phenotypes. Generally, RNAi feeding assays are performed by using one 
bacterial strain harboring one plasmid at a time. To obtain multiple gene knockdowns, howev-
er, a feeding approach with multiple dsRNA producing strains is most useful. For predicting 
the efficacy of the selected CYP35A dsRNA feeding constructs as well as to control side-ef-
fects among each other, specific RT-PCRs were performed. N2 wild type worms were fed 
with each of the individual CYP35A1-5 constructs as well as with a mixture of all five feed-
ing strains. As negative control a feeding strain harboring an empty L4440 vector was used. 
Furthermore, 1 mg/L PCB52 was added into the agar providing strong CYP35A gene induc-
tion. After a 48 h incubation period, 10 nematodes were analyzed by CYP35A1-5 and act-1 
specific RT-PCRs. It became obvious that each individual feeding construct showed a high 
specificity to its targeted gene, indicated by the absence of a RT-PCR product (Fig. 4). This 
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was valid also in the case where all five feeding strains were used in a mixed bacterial feeding 
cocktail, resulting in a complete loss of detectable CYP35A1-5 specific mRNA (Fig. 4, last 
lane). A strong cross-reactivity was found between CYP35A3 and A4 (Fig. 4, rows 3 and 4, 
lanes 3 and 4).Similarly, the A3 feeding construct knocked down CYP35A4 expression, the 
A4 construct the expression of CYP35A3 and the A2 feeding construct disabled CYP35A1 
expression  (Fig.  4,  rows  1,  lanes  2).  Only  CYP35A2 and  A5  gene  expression  could  be 
knocked down exclusively by its specific dsRNA construct. Because of its significantly lower 
homology CYP35C1 was not included in this cross-reactivity test.
CYP35A gene knockdown phenotype
Although multiple CYP35A1-5 RNAi succeeded in the intended gene silencing of the 
entire 35A subfamily, the inclusion of available cyp-35 knock-out strain is desirable. The alle-
les cyp-35A2 (gk317) and cyp-35A4 (ok1393) both do not show any deviant phenotype, even 
in the presence of xenobiotics at concentrations used in this study (data not shown). The same 
results  were obtained with the derived homozygous double mutant  XA6700, generated by 
crossing cyp-35A2 (gk317) and cyp-35A4 (ok1393). Besides the unchanged phenotype, the re-
production rate remained constant in comparison to the wild type, even following the expo-
sure to fluoranthene, PCB52, lansoprazole, or atrazine (Fig. 5). Cytochrome P450s are well 
known for their redundancy, so that more than one isoenzyme is capable of metabolizing a 
single  agent.  The intention  to  knockdown all  CYP35A/C forms  was achieved by feeding 
XA6700 CYP35A1, A3, A5 and C1 dsRNA. Again, the CYP35A/C depleted worms resem-
bled wild type in terms of morphology and reproduction rate under control condition. Howev-
er in the presence of any of the four xenobiotics, reproduction increased in comparison to N2 
wild type (Fig. 5).
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Discussion
CYP35 gene expression and xenobiotics
A systematic gene expression screen of  C. elegans cytochrome P450 genes revealed 
that almost all CYP35 forms are moderately or strongly inducible by different xenobiotics 
[11]. This report focused on CYP35A1, A2, A5, and C1, all of which were basally expressed 
and displayed a strong inducibility. It is important to add that the missing CYP35A forms 3 
and 4 are just as well inducible as the other four selected forms [11]; however, their basal ex-
pression is often hardly detectable. From the four xenobiotics used in the recent investigation, 
PCB52, fluoranthene, and lansoprazole were found to be able to induce CYP35 gene expres-
sion significantly in a concentration dependent relationship. In case of atrazine, an approxi-
mately 100-fold increase in concentration was necessary to cause a moderate induction.
All four xenobiotics are known inducers of human CYP forms [27] as well as C. ele-
gans CYPs [11]. Lansoprazole, like other benzimidazole derivates, is both a potent inducer of 
human CYP forms (1A1, 1A2 and 1B1) [28, 29] and a suitable P450 substrate (3A4, 2C18, 
2C19) [30, 31].  Fluoranthene is a rather weak inducer of CYP1A1 and 1B1 [32, 33].  For 
atrazine, heterologously expressed human CYP1A1 and A2 were described as the major P450 
species metabolizing this substance [34]. Moreover, this s-triazine was found to be able to in-
crease  7-ethoxyresorufin  O-deethylase  (EROD),  7-methoxyresorufin  O-demethylase 
(MROD),  and  7-pentoxyresorufin  O-depentylase  (PROD)  activities  significantly  [35],  all 
closely related to P450 1A forms.
The regulation of mammalian CYP1A is well understood. It is based on the aryl hy-
drocarbon receptor complex (AHR-ARNT) binding to the xenobiotic response element (XRE) 
in the CYP1A promoter region [for review, see 36].  Even though CYP35A/C transcription 
can be activated by inducers of the CYP1A subfamily, there is no significant homology of the 
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derived amino acid sequences. The highest homologies exist to CYP family 2C forms. It is 
important to add that in C. elegans, homologous proteins to the regulators AHR and ARNT 
could be identified, designated as ahr-1 and aha-1, respectively [37]. In addition, XRE like el-
ements could be found in the promoter regions of almost all CYP35 genes. In  ahr-1 minus 
worms (ju145),  however, the strong CYP35A/C gene expression induced by PCB52, lanso-
prazole, and fluoranthene was not affected at all (data not shown). Powell-Coffman’s labora-
tory recently demonstrated [38, 39] that AHR-1 is localized in various nervous cells of C. ele-
gans and not in the intestine like P450 35A forms [11]. The obvious function of ahr-1 is the 
regulation of GABAergic motor neuron fate specification [38, 39]. To facilitate this, AHR-1 
requires AHA-1, but not Hsp90, indispensable, however, in the mediation of the PAH ligand-
activated transcription. Moreover, C. elegans AHR-1 was not able to bind a dioxin analogue 
[37] and, thus, probably has a different substrate specificity than mammalian aryl hydrocar-
bon receptors. Hence, we assume that PAH induced CYP35A/C gene expression is indepen-
dent of AHR-1. This is also confirmed by the finding that CYP35A/C gene expression is also 
inducible by PCB52. PCB52 (2,2’,5,5’-tetrachlorbiphenyl) is an ortho-substituted, non-copla-
nar PCB unable to induce mammalian CYP1A [40]. All non-dioxin like PCB congeners are 
believed to be unable to bind to AHR in C. elegans. On the other hand, these PCB congeners 
are able to bind CYP2 and 3 forms. PCB52 binds preferentially to CYP2B and to a lesser ex-
tent to CYP3A enzymes [41]. Combining all results, the xenobiotically induced CYP35A/C 
gene expression pathway seems to be different to any known mammalian CYP inducing path-




Besides the CYP inducing properties of the xenobiotic substances used, it was also im-
portant to characterize their toxic potential.  The effect of xenobiotics on the reproduction of 
test organisms is a broadly accepted test parameter and was found to be a much more sensi-
tive indicator of toxicity than lethality in  C. elegans [13].  The observed mean reproduction 
rate in control medium of about 150 offspring per worm was significantly higher than the re-
production rate of 18.9 ± 8.0 (SD) reported by Traunspurger et al. [42]. This observed differ-
ence is likely due to the culturing conditions used. Whilst Traunspurger et al. used test vessels 
placed on a shaking desk we favored a less disruptive method by reducing the volume to 0.1 
ml thereby ensuring a sufficient supply of oxygen without the need of shaking.
This modified C. elegans reproduction test produced a robust concentration dependent 
relationship to the xenobiotic substances. To date nearly all C. elegans ecotoxicological stud-
ies investigated the toxic effects of heavy metals, such as cadmium and lead. Although a com-
parison with available toxic endpoint values of other invertebrates (Tab. 2) reveals that C. ele-
gans is less sensitive to organic compounds than, for example, daphnids or oligochaetes, the 
observed order of toxicity,  based on the EC50 values (fluoranthene > PCB52 > > atrazine) 
could be confirmed. PAHs and PCBs have been classified as narcotics. In addition to death, 
exposure to narcotic chemicals also may affect sublethal processes including growth, repro-
duction, and developmental time.
Toxicity and CYP35 gene expression
It is interesting, particularly for ecotoxicological purposes, to compare effect levels of 
acute toxicity and induction thresholds of CYP35A/C gene expression, reached under sub-
acute conditions. In case of PCB52, a two-fold increase of CYP35A1, A2, and C1 gene ex-
pression was reached at 0.52 %, of the corresponding EC50 for reproduction. In the case of 
lansoprazole, 2.2 % of the EC50 induced a two-fold expression increase of CYP35A1 and A2. 
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Fluoranthene and atrazine showed a low inducing potential, where 25 % of the EC50 values 
caused a two-fold expression increase of several CYP35 genes. The main advantage of the 
gene expression test compared to the reproduction test is the increased sensitivity. The paral-
lel determination of a variety of stress inducible genes (e.g. by using DNA microarrays) will 
considerably enlarge the implementation of this approach. Depending on the selected marker 
genes, this approach has the potential to identify substance class specific effects. 
In this context, it is of fundamental importance to reveal potential relationships be-
tween the observed toxicity and the induced gene expression. Specific gene knockdown is a 
proven approach to study the function of the encoded protein in more details. Cytochromes 
P450 are noted for forming families of isoenzymes whose members are often able to act as a 
substitute for several other members. It was therefore the intention of this work to knockdown 
all six CYP35A/C forms in parallel. This was successfully achieved by a multiple RNA inter-
ference  (RNAi)  assay,  and  by  using  the  homozygous  cyp-35A2/cyp-35A4  double  mutant 
(XA6700). However, cross-reactivity, whereby multiple genes may be simultaneously target-
ed by a single dsRNA fragment, can potentially jeopardize correct interpretation of gene func-
tion.  Individual  CYP35A1-5  RNAi  by  feeding  experiments  with  induced  N2  wild  type 
demonstrated that cross-reactivity occurred in particular between CYP35A3 and A4, and, to a 
lesser extent, between CYP35A1 and A2. These results accentuate the need for testing the 
specificity of each dsRNA fragment prior to a full phenotypic analysis, in particular if it is in-
tended to produce a simultaneous knockdown of an entire subfamily of genes.
The consequences of complete CYP35A/C knockdown are rather low. There is not 
any striking abnormal phenotype, even in the presence of xenobiotic substances. When the 
brood size was taken into account, however, a surprising trend became visible. The knock-
down of CYP35A/C rescued, to some extent, the decrease in reproduction caused by PCB52 
and fluoranthene.  Some PAHs and PCBs have been shown to cause cellular transformation 
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only after metabolic activation by cytochromes P450 and epoxide hydrolases producing high-
ly reactive electrophiles [43]. In rat liver microsomes,  PCB52 is metabolized to the 3-hy-
droxy- and 3,4-dihydroxy-forms, which were further oxidized to form a reactive intermediate 
that produce quinonoid-derived protein adducts in the liver [44]. Moreover, a very reactive 
PCB52 derived arene oxide intermediate was detected both in rat and rhesus monkey liver mi-
crosomes [45]. In case of the very related 2,5,2’,5’-tetrachlorbiphenyl congener, Koga et al. 
[46] suggested that in hamster liver different P450 isoforms are involved in the 3- and 4-hy-
droxylation. The major metabolic activation pathway of fluoranthene resulting in the produc-
tion of mutagenic species involves the formation of the 2,3-diol [47] and the subsequent oxi-
dation to the 2,3-diol-1,10b-epoxide [48]. Another minor activation pathway with mutagenic 
endpoints may involve the formation of 7,8-dihydroxyfluoranthene [48]. Shimada et al. [32] 
showed that human CYP1A1 is able to activate  fluoranthene-2,3-diol.  Althgough it  is un-
known if  C. elegans is able to activate PAH and/or PCB,  preliminary experiments indicate 
that  the  worm  is  able  to  metabolize  benzo[a]pyrene  to  at  least  two metabolites  in  a  cy-
tochrome P450-dependent manner (personal communication by M. Amichot, INRA, Antibes, 
France). Recent evidence was provided that biotransformation of fluoranthene may have pro-
duced a more toxic metabolite, analyzed by Schuler et al. [49] in the invertebrate Chirnono-
mus tentans.
Metabolites acting as specific toxins has been known to occur in vertebrates and is 
well-established for PAH compounds such as benzo[a]pyrene, but there are only few studies 
with invertebrates, such as insect larvae (Chironomus) or nematodes (this study). In fact the 
subtlety of metabolic channeling in which reactive intermediates transiently appear is decisive 
for their biological effect and depends mainly on proper coupling of all involved biotrans-
forming enzymes. Our results indicate that single or several P450 35A/C forms are involved 
in  the  activation  of  fluoranthene  and/or  PCB52.  It  is  suggested  that  by  knocking  down 
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CYP35A/C gene expression the generation of more toxic metabolites is prevented, which re-
sults in an increase in reproductive capacity.
A whole-animal biomonitor and environmental realism
Xenobiotically induced gene expression and other new approaches are becoming more 
and more prevalent in biomonitoring, ecotoxicology, and stress ecology. However, they are 
still not widely accepted, which tends to retard their implementation. One reason for this is 
that these systems are not able to completely simulate the highly integrated functions of a liv-
ing organism [50]. The other reason is that usually only drastic, but ecologically almost mean-
ingless effects, like increased mortality and, less frequently, reduced reproduction, are accept-
ed as endpoints in validated and standardized biotests. Today, reliable, sensitive, and specific 
test systems are needed, in particular for risk assessment of low-level mixtures of xenobiotics 
in the environment which affect both wildlife and human health on a subcellular level. Fur-
thermore, the chemical stress by man-made compounds must be differentiated from common 
natural stresses the organisms are exposed to. The natural stress may be caused by environ-
mental matrices, such as humic substances. This applies particularly to a soil inhabitant, such 
as C. elegans. That means that all defense systems that respond to xenobiotic chemicals, must 
have evolved by natural stressors, and the response to xenobiotic exposure is only an addi-
tional, but severe, chemical stress. In this respect, it has recently been shown that humic sub-
stances have the potential to act as ‘natural’ xenobiotics [51] causing a modulation of off-
spring number [52, 53].
Using sensitive and reproducible detection methods, such as RT-PCR, it is possible to 
establish significant pollution and natural stress induced changes of specific gene expression 
and to generate accurate new assays. As shown, one main intention of this paper was to reveal 
a new link between toxicity and upstream induced gene expression. Future studies will show 
17
whether or not these approaches will be able to distinguish between natural and man-made 
chemical stresses.
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 Table 1
















Atrazine Lumbriculus variegatus LC50 37.10a b
Daphnia pulex EC50 5.00 [32]
Daphnia magna LC50 21.50a b
Helobdella stagnalis LC50 9.00 [32]
C. elegans EC50 86.64 c
Fluoranthene Lumbriculus variegatus LC50 > 0.178 [33]
Daphnia magna LC50 0.117 [33]
C. elegans EC50 0.90 c
PCB52 Enchytraeus crypticus LOEC(70%) 2.00 [mg/kg soil] d
C. elegans EC50 15.61 c
All shown EC50/LOEC values correspond to the reproduction. L. variegates and E. cyrpticus – 
Oligochaete worms; T. tubifex – Tubificid worm; Daphnia spec. – Water flea; H. stagnalis  
Freshwater leech
a Average species LC50 value [b] calculated for each chemical/species combination by adding 
the LC50 values for each study and dividing by the number of studies.
b http://www.pesticideinfo.org (resource of the Pesticide Action Network North America)
c This study
d http://anubis.uba.de/etox//bin/default.asp (ETOX database, a resource of the German Fed-
eral Office for Environment – UBA)
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Fig. 1. CYP mRNA levels in control and xenobiotically induced worms determined by RT-
PCR. Pictures are a representative image from three replicated analyses. *control without 0.3 
% DMSO in the medium.
24
Fig. 2. Induction of CYP35A/C gene expression in response to (A) fluoranthene, (B) PCB52, 
(C) lansoprazole, and (D) atrazine. Shown are relative data as ×-fold increase of CYP35 gene 
expression normalized to act-1 expression. The means for three trails are semi-log plotted, er-
ror bars denote SD (n=3). The mean of the control (C), with 0.3 % DMSO in the medium, 
corresponds to 1. The dotted line marks a two-fold increase of CYP35 specific gene expres-
sion.
25
Fig. 3. Xenobiotically  induced  decrease  in  reproductive  capacity.  The  F1  offspring  was 
counted after a 96 h exposure in liquid medium (n=12); shown are relative data in percent. 
The mean of the control (C) with 0.3 % DMSO in the medium corresponds to 100 % repro-
duction. The data are semi-log plotted and each  outlier is indicated:  (A)  fluoranthene, (B) 
PCB52, (C) lansoprazole, and (D)  atrazine. The effect concentrations were determined ac-
cording to Finney’s probit analysis [26]. *p<0.05.
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Fig.4. Cross reactivity of CYP35A1-5 RNAi by feeding assays. Pictures show typical images 
of a ten-worm RT-PCR assay loaded on an agarose gel. N2 wild type worms were cultivated 
for 48 h on single feeding plates (lanes A1-A5), control plates (lane C), and multiple feeding 
plates (lane Mix), respectively. In each case all five CYP35A specific RT-PCR (rows 1-5) and 
an act-1 specific RT-PCR (row 6) was performed.
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Fig. 5. CYP35A/C gene knockdown diminishes xenobiotically affected reproduction decline. 
L1 larvae of N2 wild type, XA6700 alone and combined with CYP35A/C RNAi by feeding, 
respectively, were cultivated on agar plates in the absence or presence of four different xeno-
biotics (n=12). The amount of complete F1 offspring are presented in box plots showing each 
outlier. *p<0.05; **p<0.01.
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